![Gregg Stephen Sando](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregg Stephen Sando
Direttore/Membro del Consiglio presso Diagnostics for the Real World (Europe) Ltd.
Posizioni attive di Gregg Stephen Sando
Società | Posizione | Inizio | Fine |
---|---|---|---|
Diagnostics for the Real World (Europe) Ltd.
![]() Diagnostics for the Real World (Europe) Ltd. Miscellaneous Commercial ServicesCommercial Services Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Gregg Stephen Sando
Precedenti posizioni note di Gregg Stephen Sando
Società | Posizione | Inizio | Fine |
---|---|---|---|
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2006 | 01/08/2018 |
Amministratore Delegato | 01/01/2006 | 01/08/2018 | |
Fondatore | 24/09/2009 | 01/08/2018 | |
Cell Medica Switzerland AG
![]() Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Presidente | - | - |
Formazione di Gregg Stephen Sando
Imperial College London | Graduate Degree |
The University of Chicago | Masters Business Admin |
Harvard University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Stati Uniti | 3 |
Svizzera | 2 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Diagnostics for the Real World (Europe) Ltd.
![]() Diagnostics for the Real World (Europe) Ltd. Miscellaneous Commercial ServicesCommercial Services Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
Cell Medica Switzerland AG
![]() Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Gregg Stephen Sando
- Esperienza